Introduction: The Enterococcus genus is a common cause of nosocomial infections, with vancomycin-resistant enterococci (VRE) posing a significant treatment challenge.
Method: This retrospective study, spanning ten years (2012 to 2021), analyzes antimicrobial susceptibility patterns of species from clinical samples in a Saudi Arabian tertiary care hospital.
Result: A total of 1034 Enterococcus isolates were collected, 729 from general wards and 305 from intensive care unit (ICU) patients. VRE accounted for 15.9% of isolates. was the most common species (54.3% of isolates and 2.7% of VRE), followed by (33.6% of isolates and 41.2% of VRE). exhibited the highest resistance to ciprofloxacin (84.1%), ampicillin (81.6%), and rifampicin (80%), with daptomycin (0.6%) and linezolid (3.1%) showing the lowest resistance. In , ciprofloxacin resistance was highest (59.7%), followed by rifampicin (20.1%) and ampicillin (11.8%). Daptomycin (0%), linezolid (1.5%), and vancomycin (2.7%) had the lowest resistance. VRE cases had higher mortality rates compared to vancomycin-sensitive enterococci (VSE).
Conclusion: Eight different strains of were identified. was the most commonly identified strain, while had the highest percentage of VRE. VRE cases had a significantly higher mortality rate than VSE cases.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11171566 | PMC |
http://dx.doi.org/10.3390/diagnostics14111190 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!